Efficacy and its determinant factors of donepezil monotherapy or combined therapy with low dose quetiapine or Yi-gan san for behavioral and psychological symptoms of dementia(BPSD): prospective observational study among hospitalized patients.

Trial Profile

Efficacy and its determinant factors of donepezil monotherapy or combined therapy with low dose quetiapine or Yi-gan san for behavioral and psychological symptoms of dementia(BPSD): prospective observational study among hospitalized patients.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 May 2016

At a glance

  • Drugs Quetiapine (Primary) ; TJ 54 (Primary) ; Donepezil
  • Indications Dementia
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 May 2011 New trial record
    • 01 Nov 2010 Status changed from not yet recruiting to recruiting University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top